Dengue vaccine, Dengvaxia receives FDA nod for endemic regions
by Press Release from Outbreak News Today on (#4EAP1)
The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas. Dengue is endemic in ["]
The post Dengue vaccine, Dengvaxia receives FDA nod for endemic regions appeared first on Outbreak News Today.